R&D

Partnership

New Pipeline

Seoul National University
  • - Seoul National University
  • - Open innovation

Co-development

  • amyloid solution
  • yungjin pharm
  • aptamer sciences

Indication Expansion

  • - Other CNS
  • - Oncology
  • - Immunology
neuramedy logo
  • - Tomaralimab
  • - Small molecule
  • - Brain delivery
  • - Biomaker
  • - Diagnosis

First & best solutions for CNS disorders

- Our Partners

  • Amyloid Solution

    Amyloid Solution is an R&D focused company focusing on Alzheimer’s disease.
    Neuramedy is partnering with Amyloid Solution for the research of Alzheimer’s disease.

  • Aptamer Sciences

    Aptamer Sciences is a bio venture focusing on aptamer technology platform for discovery and development of innovative therapeutic and diagnostic platforms. Neuramedy is partnering with Aptamer Science for the improvement of its antibodies.

  • Yungjin Pharm

    Yungjin Pharm is a leading Korean pharmaceutical company founded in 1952. Joining KT&G group In 2004, the company is actively transforming itself into a global pharmaceutical company. Neuramedy is partnering with Yungjin Pharm for the discovery of lead compounds for Parkinson’s disease.